Introduction {#Sec1}
============

Comorbidity between sleep disorders is often seen in daily clinical routine and is gaining more and more scientific attention in sleep research \[[@CR1]--[@CR5]\]. The prevalence of Restless Legs Syndrome (RLS) in patients with Sleep Apnea Syndrome varies between 7 and 36% \[[@CR6], [@CR7]\], which is higher than in normal population \[[@CR7], [@CR8]\]. It is known that Sleep Apnea Syndrome (SAS) as well as RLS are associated with sleep difficulties such as problems initiating and maintaining sleep, a short sleep time and impaired daytime functioning \[[@CR1], [@CR2], [@CR9]\]. Moreover, SAS as well as RLS frequently seem to be associated with depression \[[@CR10], [@CR11]\]. RLS as well as SAS may be associated with insomnia specific emotional and cognitive symptoms of insomnia \[[@CR12], [@CR13]\]. However, there is a rare data about the question, whether patients who are suffering from both disorders (SAS-RLS) are more affected by psychological symptoms of insomnia disorder than patients just having SAS. The symptoms of insomnia disorder exceed disturbed sleep. These patients complain about impaired daytime performance and typically show sleep-related worries \[[@CR14]\] that are recognized to fuel insomnia specific hyperarousal. The fact that SAS-RLS show more insomnia specific psychological symptoms may give further information regarding the etiology of insomnia as well as the need for possible additional treatment options such as Cognitive Behavior Therapy for Insomnia.

Rodrigues et al. compared 13 SAS and 17 SAS-RLS regarding sleep quality, polysomnographic data, daytime sleepiness, depression, and fatigue without finding any differences \[[@CR15]\]. Another study comparing SAS with SAS-RLS showed that daytime sleepiness as well as difficulties initiating and maintaining sleep more than 3 times per week were more pronounced in SAS-RLS than in SAS \[[@CR7]\].

In this study, we retrospectively investigated a large sample of inpatients suffering from SAS or SAS-RLS. All patients were studied regarding insomnia specific symptoms including severity, objective sleep data and subjective sleep parameters, and daytime fitness. We also assessed depression scores since it is known that insomnia patients show some overlap with depressive syndrome \[[@CR16]\]. Furthermore, impaired daytime performance as a consequence of sleep loss is an issue in every sleep disorder. For patients suffering from insomnia, data is controversial suggesting a hyperarousal for compensating tiredness \[[@CR17]\]. It was therefore interesting to investigate performance in psychomotoric tests in our samples.

Materials and methods {#Sec2}
=====================

A single-center retrospective inpatient study using charts and polysomnographic data was performed.

Patients {#Sec3}
========

All patients were diagnosed and treated in the sleep laboratory of Sleep Disorder Center Regensburg, Germany, in 2015 and 2016 in an inpatient setting.

Every patient had had a face-to-face interview and a physical examination in our sleep-clinic by a sleep specialist. Inclusion criteria were defined as (American Academy of Sleep Medicine: International Classification of Sleep Disorders: Diagnostic and Coding anual, 2005) AHI ≥ 5/h combined with cardinal symptoms of SAS or AHI ≥ 15/h. Patients with predominant obstructive events were included. RLS criteria (IRLSSG in 2002) were as follows: (1) urge to move the legs, usually accompanied by discomfort in the lower limbs (2) occurrence or worsening of symptoms in situations of rest or inactivity (e.g., in bed) (3) partially or totally relief of symptoms through movement, and (4) symptoms are worse or solely in the evening. RLS symptoms including frequency and severity were explored during the face-to-face interview to avoid false-positive RLS diagnoses. Exclusion criteria were the presence of severe psychiatric disorders such as a psychosis, cognitive disorder, alcohol abuse, or difficulties in German language and Parkinson disease. Patients who received RLS treatment or were treated with CPAP at the time of admission were also excluded.

All the untreated patients with SAS who were admitted for the first time to our sleep laboratory between 2015 and 2016 were screened for analysis. Fourteen patients were excluded because of following reasons: psychosis (*N* = 5), cognitive disorder (*N* = 4), difficulties in German language (*N* = 3), alcohol abuse (*N* = 1), Parkinson disease (N = 1), or incomplete data (*N* = 20).

Measurements {#Sec4}
============

Polysomnography {#Sec5}
---------------

A full cardio-respiratory polysomnographic recording night was performed and scored by sleep specialists according to the manual of the American Academy of Sleep Medicine. A polysomnography was performed in a separated bedroom in our sleep laboratory located in the clinic. During baseline nights, our usual recording times were conducted (10 pm to 6 am). The polysomnography included the electroencephalogram (frontal, central, and occipital leads, referenced to the contralateral mastoid), electrooculogram (alternative derivation, E~1~-F~pz~ and E~2~-F~pz~), electromyogram of the chin muscle, tibialis anterior muscles bilaterally, nasal airflow (pressure transducer) thoracic and abdominal respiration (uncalibrated induction plethysmography), oxygen saturation, electrocardiogram, and body position. Hypopnea definition B (alternative) was used. Sleep stages, periodic leg movements, and respiratory events were classified by a trained staff member according to the AASM manual. Respiratory event-associated movements were not classified in a separate category.

The following sleep parameters were analyzed: sleep onset latency (SOL); total sleep time (TST); wake time after sleep onset (WASO); sleep efficiency (SE); and NREM1, NREM 2, NREM 3, and REM sleep stages in % of sleep period time (SPT).

Psychological tests {#Sec6}
-------------------

Regensburg Insomnia Scale (RIS) is a ten-item self-report inventory to evaluate the psychophysiological symptoms of insomnia, 0--40 scores, cut-off 12 \[[@CR18]\]. Epworth Sleepiness Scale (ESS) is an eight-item questionnaire for measuring daytime sleepiness in adults, 0--24 scores, cut-off 10. Beck Depressions Inventory-II (BDI-II) 0--63 score, cut-off 12. In the morning after polysomnography, a Morning Questionnaire was given asking for sleep duration (in minutes), time to fall asleep (in minutes), and number of awakenings (unpublished). A sustained attention test (VIGIL, S1, Quatember and Maly) of the Vienna Test System (Version 5.10, Schuhfried GmbH, Mödling, Austria) was performed in all subjects.

Analysis {#Sec7}
--------

For the statistical analysis, SPSS 24.0.0.1 (SPSS Inc., Chicago, IL, USA) was used. The two-tailed significance level was defined as *p* \< .05.

Regarding age and BMI, SAS and SAS-RLS were compared by using student's *t* tests. Differences in sex were calculated by using Chi^2^ test. In case of significant differences, age, gender, or BMI were included as cofactors in further comparisons. For calculating the differences in scores in ESS, BDI, RIS, parameters of Quatember-Maly, and sleep parameters, ANOVA was used. Missing data in ESS, BDI, RIS, or vigilance test were replaced by mean substitution (SPSS).

Results {#Sec8}
=======

Sample {#Sec9}
------

The sample consisted of 202 patients showing sleep apnea (mean age of 55 years, SD = 11.0) with 71 (35%) women. Mean BMI was 31 kg/m^2^ (SD = 6). Forty-two patients (21%) had comorbid RLS.

Clinical differences between SAS-RLS and SAS {#Sec10}
--------------------------------------------

In SAS-RLS, the number of women (60%) was significantly higher (*p* \< .0005) than in SAS (29%). Gender was used as covariate in further calculations. No differences in age or BMI were found (see Table [1](#Tab1){ref-type="table"}).Table 1Epidemiological data of SAS-RLS and SAS160 SAS42 SAS-RLS*p* valueAge54 (σ = 11.4)57 (σ = 8.8).145 (*t* test)Sex♀46 (29%),♂114 (71%)♀25 (60%),♂17 (40%)\< .0005 (Chi^2^)BMI31 (σ = 5.4, *N* = 153)32 (σ = 8, *N* = 40).301 (*t* test)

Insomnia specific differences between SAS-RLS and RLS {#Sec11}
-----------------------------------------------------

The RIS scores in SAS-RLS were significantly higher (*p* = .005). Significant differences were found in the items "I wake up too early", "I wake up from the slightest sound", "I feel that I have not slept all night", "I think a lot about my sleep", and "I am afraid to go to bed because of my disturbed sleep" (see Table [2](#Tab2){ref-type="table"}).Table 2Differences between 160 SAS and 42 SAS-RLS in insomnia symptoms measured by Regensburg Insomnia Scale (RIS)160 SAS42 SAS-RLSANOVARIS itemsMean and SDMean and SDFactor groupFactor genderRIS score (*N* = 198)15.9 (σ = 7.88)19.6 (σ = 1.14)*F* = 7.931; *p* = .005*F* = 5.077; *p* = .025How many minutes do you need to fall asleep?0.88 (σ = 1.14)1.02 (σ = 1.24)*F* = .471; *p* = .493*F* = .154; *p* = .696How many hours do you sleep during the night?1.03 (σ = 0.92)1.19 (σ = 0.99)*F* = 1.001; *p* = .318*F* = .760; *p* = .385My sleep is disturbed2.25 (σ = 1.28)2.52 (σ = 1.4)*F* = 1.457; *p* = .229*F* = .286; *p* = .594I wake up too early2.12 (σ = 1.24)2.58 (σ = 1.31)*F* = 4.461; *p* = .036*F* = 4.581; *p* = .034I wake up from the slightest sound1.69 (σ = 1.34)2.5 (σ = 1.27)*F* = 12.295; *p* = .001*F* = 9.614; *p* = .002I feel that I have not slept all night1.88 (σ =2.02)2.36 (σ = 1.25)*F* = 8.117; *p* = .005*F* = 6.019; *p* = .015I think a lot about my sleep1.81 (σ = 1.28)2.31 (σ = 1.28)*F* = 4.956; *p* = .027*F* = 4.529; *p* = .035I am afraid to go to bed because of my disturbed sleep1.17 (σ = 1.33)1.81 (σ = 1.4)*F* = 7.405; *p* = .007*F* = 5.895; *p* = .016I feel fit during the day2.23 (σ = 1.22)2.48 (σ = 1.33)*F* = 1.284; *p* = .258*F* = 1.191; *p* = .277I take sleeping pills in order to get to sleep0.8 (σ = 1.41)0.88 (σ = 1.5)*F* = .12; *p* = .73*F* = .115; *p* = .734

Differences in sleep parameters between SAS and SAS-RLS {#Sec12}
-------------------------------------------------------

SAS-RLS and SAS did not differ in any PSG parameters, except for SAS-RLS showing a tendency of higher arousals indices (*p* = .056). There was a significant difference seen in PLM-Index (*p* = .04) and PLM-Arousal-Index (*p* \< .0005) between groups (see Table [3](#Tab3){ref-type="table"}).Table 3Polysomnographic data of 160 SAS patients and 42 SAS-RLS patients160 SAS42 SAS-RLSMean and SDMean and SDFactor groupFactor GenderTime in bed (TIB)452 min (σ = 23.68)451 min (σ = 34.2)*F* = .878; *p* = .878*F* = .014; *p* = .907Sleep period time (SPT)420 min (σ = 41.82)431 min (σ = 44.84)*F* = 2.167; *p* = .143*F* = 2.7; *p* = .102Total sleep time (TST)338 min (σ = 70.95)336 min (σ = 68.16)*F* = .014; p = .907*F* = .022; *p* = .881Wake time after sleep onset (WASO)85 min (σ = 55.41)95 min (σ = 51.4)*F* = 1.267; *p* = .262*F* = 1.674; *p* = .197Sleep latency (SOL)25 min (σ = 31.82)17 min (σ = 20.08)*F* = 2.486; *p* = .116*F* = 4.379; *p* = .038Sleep efficiency (SE)74% (σ = 16.08)74% (σ = 13.03)*F* = .007; *p* = .933*F* = .000; *p* = .990N1 (% of SPT)16% (σ = 9.05)16% (σ = 8.94)*F* = .150; *p* = .699*F* = .022; *p* = .883N2 (% of SPT)37% (σ = 11.02)35% (σ = 11.01)*F* = 1.092; *p* = .297*F* = .696; *p* = .405N3 (% of SPT)15% (σ = 9.69)16% (σ = 10.53)*F* = .168; *p* = .682*F* = .282; *p* = .596REM (% of SPT)11% (σ = 6.01)11% (σ = 6.16)*F* = .013; *p* = .910*F* = .033; *p* = .857Arousal index (AI)34/h (σ = 19.52)41/h (σ = 20.03)*F = 3.682; p = .056F* = 4.926; *p* = 028PLM index31/h (σ = 27.35)41/h (σ = 35.45)*F* = 4.272; *p* = .040*F* = 4.007; *p* = .047PLM-Arousal index6/h (σ = 7.25)14/h (σ = 15,03)*F* = 24.473; *p* \< .0005*F* = 20.669; p \< .0005Apnea-Hypopnea index (AHI)27/h (σ = 28,14)27/h (σ = 19.71)*F* = .000; *p* = .991*F* = .159; *p* = .690Apnea index15/h (σ = 23.71)9/h (σ = 12.18)*F* = 2.733; *p* = .100*F* = 1.195; *p* = .276Desaturation index20/h (σ = 21.47)19% (σ = 20.04)*F* = .128; *p* = .721*F* = .013; *p* = .908Mean saturation93% (σ = 1.89)92% (σ = 1.82)*F* = .784; *p* = .377*F* = .238; *p* = .627Arousal-breathing index17/h (σ = 18.96)18/h (σ = 14.04)*F* = .124; *p* = .726*F* = .682; *p* = .410

The analysis of the scores of ESS, BD-III, Morning questionnaire, and parameters of sustained attention test did not show any differences between SAS and SAS-RLS (see Tables [4](#Tab4){ref-type="table"} and [5](#Tab5){ref-type="table"}).Table 4Epworth Sleepiness Scale and Beck Depressions Inventory-II of SAS and SAS-RLSSASSAS-RLSFactor groupFactor genderESS9.5 (σ = 5,09)11.0 (σ = 4,55)*F* = 2.918; *p* = .089*F* = 2.616; *p* = .107Sitting and reading1.2 (σ = 0,96)1.67 (σ = 0,93)*F* = 7.828; *p* = .006*F* = 7.105; *p* = .008Watching TV2.01 (σ = 0,98)2.25 (σ = 0,8)*F* = 1.953; *p* = .164*F* = 1.407; *p* = .237Sitting, inactive in a public place1.32 (σ = 1,03)1.37 (σ = 1,07)*F* = .093; *p* = .761*F* = .033; *p* = .857As a passenger in a car for an hour without a break1.11 (σ = 1,04)1.41 (σ = 0,97)*F* = 2.916; *p* = .089*F* = 1.705; *p* = .193Lying down to rest in the afternoon when circumstances permit2.13 (σ = 0,99)2.15 (σ = 1,01)*F* = .015; *p* = .903*F* = .148; *p* = .701Sitting and talking to someone0.33 (σ = 0,5)0.52 (σ = 0,78)*F* = 3.581; *p* = .060*F* = 4.296; *p* = .040Sitting quietly after a lunch without alcohol1.08 (σ = 0,99)1.27 (σ = 1,03)*F* = 1.158; *p* = .283*F* = .768; *p* = .382In a car while stopping for a few minutes in the traffic0.31 (σ = 0.6)0.34 (σ = 0.66)*F* = .102; *p* = .750*F* = .554; *p* = .458**[BDI]{.ul}**12.8 (σ = 9.77)15.9 (σ = 10.63)*F* = 2.883; *p* = .091*F* = 1.67; *p* = .198A-Feeling sad0.43 (σ = 0.72)0.32 (σ = 0.63)*F* = .68; *p* = .411*F* = 1.166; *p* = .282B-Discouraged about the future0.45 (σ = 0.85)0.58 (σ = 0.89)*F* = .638; *p* = .426*F* = .449; *p* = .504C-Failure0.41 (σ = 0.77)0.59 (σ = 0.83)*F* = 1.589; *p* = .209*F* = .467; *p* = .495D-Satisfaction0.81 (σ = 0.74)0.85 (σ = 0.74)*F* = .097; *p* = .755*F* = .217; *p* = .642E-Guiltiness0.45 (σ = 0.76)0.51 (σ = 0.65)*F* = .210; *p* = .647*F* = .000; *p* = .994F-Feel being punished0.55 (σ = 1.03)0.78 (σ = 1.16)*F* = 1.44; *p* = .232*F* = 1.859; *p* = .174G-Disappointment0.38 (σ = 0.66)0.57 (σ = 0.77)*F* = 2.293; *p* = .132*F* = 1.145; *p* = .286H-Self-concept0.53 (σ = 0.69)0.68 (σ = 0.85)*F* = 1.226; *p* = .27*F* = .341; *p* = .56I-Suicidal thoughts0.24 (σ = 0.44)0.35 (σ = 0.43)*F* = .021; *p* = .885*F* = .192; *p* = .662J-Crying0.34 (σ = 0.76)0.65 (σ = 1.06)*F* = 4.121; *p* = .044*F* = 2.728; *p* = .10K-Irritation0.83 (σ = 0.84)0.86 (σ = 0.89)*F* = .041; *p* = .84*F* = .197; *p* = .658L-Interest in other people0.51 (σ = 0.77)0.7 (σ = 0.85)*F* = 1.772; *p* = .185*F* = 1.795; *p* = .182M-Come to a decision0.93 (σ = 0.84)0.95 (σ = 0.82)*F* = .011; *p* = .916*F* = .061; *p* = .805N-Feel looking un−/attractive0.5 (σ = 0.86)0.86 (σ = 1.13)*F* = 4.595; *p* = .033*F* = 1.587; *p* = .209O-Able to do work1.01 (σ = 0.82)1.08 (σ = 0.72)*F* = .249; *p* = .619*F* = .167; *p* = .683P-Sleep1.23 (σ = 0.92)1.68 (σ = 0.92)*F* = 6.894; *p* = .009*F* = 4.943; *p* = .027Q-Getting tired1.13 (σ = 0.82)1.38 (σ = 0.72)*F* = 3.077; *p* = .081*F* = 2.59; *p* = .109R-Appetite0.26 (σ = 0.6)0.22 (σ = 0.42)*F* = .151; *p* = .698*F* = .103; *p* = .749S-Losing weight0.33 (σ = 0.77)0.23 (σ = 0.63)*F* = .491; *p* = .485*F* = .685; *p* = .409T-Worrying about health0.64 (σ = 0.72)0.8 (σ = 0.62)*F* = 1.614; *p* = .206*F* = 1.97; *p* = .162U-Interest in sex0.85 (σ = 1.03)1.35 (σ = 1.27)*F* = 6.346; *p* = .013*F* = 1.67; *p* = .198Table 5Sustained attention test of SAS and SAS-RLSSASSAS-RLSFactor groupFactor GenderMean reaction time (sec.)0.51 s (σ = 0.11)0.54 s (σ = 0.11)*F* = 1.468; *p* = .227*F* = .185; *p* = .667Number of omissions4.77 (σ = 8.89)6.05 (σ = 14.2)*F* = .485; *p* = .487*F* = .087; *p* = .768False-positive reactions3.59 (σ = 9.7)2.74 (σ = 3.41)*F* = .286; *p* = .593*F* = .654; *p* = .42

Discussion {#Sec13}
==========

The prevalence of 21% of sleep apnea patients suffering from RLS in our sample is comparable to the data published in ISAC study \[[@CR1], [@CR7]\], and it is higher than the prevalence of RLS found in normal population (4 to 14%) \[[@CR8], [@CR19]\]. The higher proportion of women in our sample of SAS-RLS could be explained by the high prevalence of women in RLS in general population \[[@CR8], [@CR20]\]. However, there are also studies finding no difference between women and men regarding RLS prevalence \[[@CR21]\]. Further studies should clarify this issue.

Our main result is that SAS-RLS complained more psychological insomnia specific symptoms than SAS. It has been shown before that RLS patients may show insomnia specific characteristics such as sleep disruptive habits and cognitions \[[@CR12]\], similar data was found in patients suffering from sleep apnea \[[@CR13]\]. To our knowledge, this is the first study showing a higher incidence of insomnia specific symptoms such as sleep related worries in patients suffering from both. The question whether disturbed sleep quality is caused by RLS, SAS or insomnia disorder cannot be cleared in this study and should be clarified by further research. However, the fact that insomnia comorbid with other sleep disorders should be treated with insomnia-specific methods is an important feature of insomnia management \[[@CR22]\]. Therefore a combination of SAS and RLS therapy with elements of Cognitive Behavior Therapy for Insomnia such as psycho-education could be beneficial.

Findings in the PSG data of SAS and SAS-RLS are comparable to previous data showing no differences regarding TST, SE, WASO, stages of sleep, or breathing parameters \[[@CR15]\]. However, since SAS-RLS show more insomnia specific symptoms, it should have been expected that they display more difficulties falling asleep in our sleep laboratory night. This was not the case and probably due to the sleep lab situation and the fact that we just had one diagnostic night. Further studies with more successive nights would be useful to clarify this topic. the sleep structure of both SAS and SAS-RLS tended to be low, but to a similar extent. Arousal Index, PLM Index, and PLM-Arousal Index were more pronounced in SAS-RLS. This is in line with earlier data showing that the RLS in SAS patients was an independent risk factor for difficulties maintaining sleep \[[@CR1]\]. Our results showing that SAS-RLS patients suffer more from light sleep and early awakening as had been measured with the RIS may reflect this data.

However, the negative impact of periodic limb movements in sleep on sleep quality has been discussed controversially \[[@CR23], [@CR24]\]. The fact that we did not address respiratory event associated movements \[[@CR25]\] can be seen as a limiting factor of our study. These events are known to be more frequent in patients showing sleep apnea comorbid with periodic leg movements in sleep. It is hypothesized that they indicate a more severe form of breathing disorder. A recently published study shows that CPAP therapy enhances PLM indices in SAS patients \[[@CR26]\]. Further studies are necessary to address this complex phenomenon. In our study, we found a trend toward more arousals in SAS-RLS.

A secondary result is the fact that there is no difference in the degree of depression between SAS and SAS-RLS. Both SAS and SAS-RLS had mean BDI-II score of 13 and 16 indicating mild depressiveness. Depressive symptoms in SAS or RLS had been shown before \[[@CR27], [@CR28]\]. Moreover, SAS and SAS-RLS did not differ in psychomotoric performance, both showing impaired performance.

Conclusion {#Sec14}
==========

RLS is a frequent comorbid disorder in patients suffering from SAS. SAS-RLS show a higher degree in insomnia specific psychological symptoms and may benefit from the elements of insomnia specific Cognitive behavior therapy.
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